Immune checkpoint inhibitors for advanced pancreatic cancer

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the benefits and harms of immune checkpoint inhibitors (ICIs), as monotherapy or in combination (with chemotherapy or targeted therapy), for people with advanced pancreatic cancer compared with chemotherapy, targeted therapy, or placebo.

This is a protocol.